Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189917
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2005-09-11
Brief Title:
Safety Tolerability and Immune Response of IMVAMUNE MVA-BNSmallpox Vaccine in Patients With Atopic Disorders
Sponsor:
Bavarian Nordic
Organization:
Bavarian Nordic
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hay Fever |
| Dermatitis Atopic |
Keywords: